ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Estimating Alloantibody Levels in Highly-Sensitized Renal Allograft Candidates Using Serial Dilutions

C. Maguire1, A. R. Tambur1, C. Schinstock2, M. D. Stegall2

1Northwestern University, Chicago, IL, 2Mayo Clinic, Rochester, MN

Meeting: 2020 American Transplant Congress

Abstract number: D-090

Keywords: Alloantibodies, HLA antibodies, Kidney transplantation, Sensitization

Session Information

Session Name: Poster Session D: Kidney Immunosuppression: Desensitization

Session Type: Poster Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

*Purpose: Despite the new Kidney Allocation System and Kidney Paired Donation, renal allograft candidates with a >99.9% cPRA still have extremely low rates of transplantation and thus remain candidates for desensitization (Clinical Transplantation, 2019). However, many of these candidates have very high levels of alloantibody, and reducing their cPRA to a level at which they will be able to receive compatible kidney transplants may be extremely difficult. It was shown that MFI values alone do not have good correlation with antibody strength. The goal of this study was to determine the level of alloantibody using serial dilutions.

*Methods: Using the LABscreen Single Antigen assay (One Lambda), we retrospectively studied 20 patients with cPRA 99.9% from two institutions. Using an MFI of 1000 as the cutoff for negative, we determined the 2n dilution that led to a cPRA <98%. Two serum samples at least 6 months apart were tested in triplicate, over 2 days, for inter- and intra-assay reproducibility; and to assess stability of dilution titer over time.

*Results: Reproducibility. Dilutions performed on the same sample in triplicate showed high reproducibility, with all titers within 1 dilution (40 samples performed in triplicate) at both time points. Changes in titer over time. Titers over time were generally stable with 75% (15/20) patients remaining within 1 dilution difference between the two time points analyzed. Five patients had titer changes >1 dilution over time. 2/5 showed titer increase – one pt received blood transfusion and the other received Cyclophosphamide. 3/5 showed titer decreased – one pt received belimumab, one had perforated jejunum and received a prednisone taper, one had no documented reason to explain change.

*Conclusions: Using serial dilutions, the titer needed to reduce cPRA to a “transplantable” level can be estimated with high accuracy. The assay has good reproducibility. Some patients may have changes in titer over time, mostly due to changes in immune parameters. This approach can be used as a surrogate endpoint for clinical trials aimed at determining the effect of therapy on alloantibody levels in these patients.

Dilution required to achieve cPRA <98% in 15 patients stable over time
Median Dilution 32 64 128 256 512 1024  2048 or greater
No. of Patients 3 2 1 3 2 1 3

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Maguire C, Tambur AR, Schinstock C, Stegall MD. Estimating Alloantibody Levels in Highly-Sensitized Renal Allograft Candidates Using Serial Dilutions [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/estimating-alloantibody-levels-in-highly-sensitized-renal-allograft-candidates-using-serial-dilutions/. Accessed May 11, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences